Why the study?
Are PAI-1 and D-dimer levels associated with asymptomatic macrovascular disease progression in type 2 diabetic women?
Are PAI-1 and D-dimer levels associated with asymptomatic macrovascular disease progression in type 2 diabetic women?
D-dimer, but not PAI-1, is associated with the presence of carotid plaque in women with type 2 diabetes, suggesting its potential utility as a biomarker for macrovascular progression.
Does not support routine biomarker use in diabetic women; leaves open prospective validation of D-dimer for macrovascular risk stratification.
Asymptomatic diabetic patients with different degrees of macrovascular complications can present different hemostatic changes. At this study, plasminogen activator inhibitor-1 (PAI-1) and D-dimer were evaluated in 12 women without diabetes and 64 type 2 diabetic women. All patients were classified into 3 different categories according to the carotid intima-media thickness (IMT) assessed by Doppler: 25 with <1 mm (normal), 15 with >1 mm and without plaque (intermediate), and 24 with stenosis lower than 50% of the vessel lumen (plaque). The results showed increased plasma D-dimer in type 2 diabetic women with carotid plaque when compared to the other groups. High levels of PAI-1 were observed in all the 3 groups of diabetic women when compared to women without diabetes. Our results suggest that high levels of PAI-1 in type 2 diabetic women are only associated with diabetes and are not associated with macrovascular progression; however, it seems that D-dimer plasma levels are associated with carotid plaque.
No takes yet. Share an insight, caveat, or question.
Soares et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: